Logo

Alnylam Licenses RNAi Patent Family to Sigma-Aldrich

Jul 19, 2005

NEW YORK, July 19 (GenomeWeb News) - Sigma-Aldrich has licensed a number of RNA interference patents known as the Kreutzer-Limmer patent family from Alnylam Pharmaceuticals to provide research products and services, the companies said today.

 

The patents cover short interfering RNAs and their use to mediate RNA interference in mammalian cells.

 

Including Sigma, 12 companies have taken licenses to Alnylam's patent estate so far, including seven reagent and service providers.

Breaking News
The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.